479 related articles for article (PubMed ID: 26292963)
41. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
[TBL] [Abstract][Full Text] [Related]
42. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
[TBL] [Abstract][Full Text] [Related]
43. Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.
Tsou PS; Rabquer BJ; Ohara RA; Stinson WA; Campbell PL; Amin MA; Balogh B; Zakhem G; Renauer PA; Lozier A; Arasu E; Haines GK; Kahaleh B; Schiopu E; Khanna D; Koch AE
Rheumatology (Oxford); 2016 Apr; 55(4):745-54. PubMed ID: 26705326
[TBL] [Abstract][Full Text] [Related]
44. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
[TBL] [Abstract][Full Text] [Related]
45. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
[TBL] [Abstract][Full Text] [Related]
46. The role and mechanism-of-action of Sema3E and Plexin-D1 in vascular and neural development.
Oh WJ; Gu C
Semin Cell Dev Biol; 2013 Mar; 24(3):156-62. PubMed ID: 23270617
[TBL] [Abstract][Full Text] [Related]
47. Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.
Andrigueti FV; Arismendi MI; Ebbing PC; Kayser C
Microvasc Res; 2015 Mar; 98():82-7. PubMed ID: 25596148
[TBL] [Abstract][Full Text] [Related]
48. Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke.
Zhou YF; Chen AQ; Wu JH; Mao L; Xia YP; Jin HJ; He QW; Miao QR; Yue ZY; Liu XL; Huang M; Li YN; Hu B
FASEB J; 2019 Apr; 33(4):4947-4961. PubMed ID: 30653356
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
[TBL] [Abstract][Full Text] [Related]
50. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
[TBL] [Abstract][Full Text] [Related]
51. Complexes of plexin-A4 and plexin-D1 convey semaphorin-3C signals to induce cytoskeletal collapse in the absence of neuropilins.
Smolkin T; Nir-Zvi I; Duvshani N; Mumblat Y; Kessler O; Neufeld G
J Cell Sci; 2018 May; 131(9):. PubMed ID: 29661844
[TBL] [Abstract][Full Text] [Related]
52. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
53. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.
Manetti M; Pratesi S; Romano E; Bellando-Randone S; Rosa I; Guiducci S; Fioretto BS; Ibba-Manneschi L; Maggi E; Matucci-Cerinic M
PLoS One; 2017; 12(8):e0183102. PubMed ID: 28797111
[TBL] [Abstract][Full Text] [Related]
54. Repulsive Sema3E-Plexin-D1 signaling coordinates both axonal extension and steering via activating an autoregulatory factor, Mtss1.
Kim N; Li Y; Yu R; Kwon HS; Song A; Jun MH; Jeong JY; Lee JH; Lim HH; Kim MJ; Kim JW; Oh WJ
Elife; 2024 Mar; 13():. PubMed ID: 38526535
[TBL] [Abstract][Full Text] [Related]
55. The combination of laser Doppler perfusion imaging and photoplethysmography is useful in the characterization of scleroderma and primary Raynaud's phenomenon.
Rosato E; Molinaro I; Rossi C; Pisarri S; Salsano F
Scand J Rheumatol; 2011; 40(4):292-8. PubMed ID: 21338324
[TBL] [Abstract][Full Text] [Related]
56. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
[TBL] [Abstract][Full Text] [Related]
57. Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Corallo C; Paulesu L; Cutolo M; Ietta F; Carotenuto C; Mannelli C; Romagnoli R; Nuti R; Giordano N
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S98-105. PubMed ID: 26005773
[TBL] [Abstract][Full Text] [Related]
58. Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins.
Nakayama H; Huang L; Kelly RP; Oudenaarden CR; Dagher A; Hofmann NA; Moses MA; Bischoff J; Klagsbrun M
Biochem Biophys Res Commun; 2015 Aug; 464(1):126-32. PubMed ID: 26086095
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.
Wang Y; Sun J; Kahaleh B
J Cell Mol Med; 2021 Jul; 25(14):7078-7088. PubMed ID: 34137496
[TBL] [Abstract][Full Text] [Related]
60. Novel photoplethysmography cardiovascular assessments in patients with Raynaud's phenomenon and systemic sclerosis: a pilot study.
McKay ND; Griffiths B; Di Maria C; Hedley S; Murray A; Allen J
Rheumatology (Oxford); 2014 Oct; 53(10):1855-63. PubMed ID: 24850874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
